China Sxt Pharmaceuticals Inc (SXTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 1,138 | 1,741 | 1,929 | 1,972 | 2,602 |
| Cost of Goods | 889 | 1,374 | 1,375 | 1,545 | 1,351 |
| Gross Profit | 249 | 367 | 554 | 426 | 1,252 |
| Operating Expenses | 8,261 | 3,421 | 3,444 | 6,579 | 6,792 |
| Operating Income | -7,123 | -2,681 | -2,515 | -5,608 | -5,190 |
| Interest Expense | 63 | 648 | 544 | 477 | 37 |
| Other Income | 981 | 25 | -39 | 150 | -182 |
| Pre-tax Income | -6,205 | -3,304 | -3,099 | -5,935 | -5,408 |
| Income Tax | N/A | N/A | N/A | N/A | 328 |
| Net Income Continuous | -6,205 | -3,304 | -3,099 | -5,935 | -5,736 |
| Net Income | $-6,205 | $-3,304 | $-3,099 | $-5,935 | $-5,736 |
| EPS Basic Total Ops | -9.13 | -348.17 | -4,265.22 | -26,543.28 | -164,686.60 |
| EPS Basic Continuous Ops | -9.13 | -348.12 | -4,282.11 | -26,543.12 | -164,641.10 |
| EPS Diluted Total Ops | -9.13 | -348.17 | -4,265.22 | -26,543.28 | -164,686.60 |
| EPS Diluted Continuous Ops | -9.13 | -348.12 | -4,282.11 | -26,543.12 | -164,641.10 |
| EPS Diluted Before Non-Recurring Items | -9.13 | -346.27 | -4,262.69 | -26,567.16 | -164,776.09 |
| EBITDA(a) | $-7,049 | $-2,598 | $-2,312 | $-5,357 | $-4,870 |